236 related articles for article (PubMed ID: 34750206)
1. Cross-roads for meta-analysis and network meta-analysis of
Graham DY; Hernaez R; Rokkas T
Gut; 2022 Mar; 71(3):643-650. PubMed ID: 34750206
[No Abstract] [Full Text] [Related]
2. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.
Rokkas T; Gisbert JP; Malfertheiner P; Niv Y; Gasbarrini A; Leja M; Megraud F; O'Morain C; Graham DY
Gastroenterology; 2021 Aug; 161(2):495-507.e4. PubMed ID: 33839101
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.
Xin Y; Manson J; Govan L; Harbour R; Bennison J; Watson E; Wu O
BMC Gastroenterol; 2016 Jul; 16(1):80. PubMed ID: 27460211
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication.
Yeo YH; Hsu CC; Lee CC; Ho HJ; Lin JT; Wu MS; Liou JM; Wu CY;
J Gastroenterol Hepatol; 2019 Jan; 34(1):59-67. PubMed ID: 30169908
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of second-line regimens for
Chang YL; Tung YC; Tu YK; Yeh HZ; Yang JC; Hsu PI; Kim SE; Wu MF; Liou WS; Shiu SI
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32883715
[TBL] [Abstract][Full Text] [Related]
6. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.
Graham DY; Lu H; Yamaoka Y
Drugs; 2008; 68(6):725-36. PubMed ID: 18416582
[TBL] [Abstract][Full Text] [Related]
7. Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship.
Graham DY; Liou JM
Clin Gastroenterol Hepatol; 2022 May; 20(5):973-983.e1. PubMed ID: 33775895
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis.
Jung YS; Park CH; Park JH; Nam E; Lee HL
Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28425141
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
[TBL] [Abstract][Full Text] [Related]
10. First-line
Yeo YH; Shiu SI; Ho HJ; Zou B; Lin JT; Wu MS; Liou JM; Wu CY;
Gut; 2018 Jan; 67(1):20-27. PubMed ID: 27670375
[TBL] [Abstract][Full Text] [Related]
11. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
12. Understanding and appreciating sequential therapy for Helicobacter pylori eradication.
Graham DY; Rimbara E
J Clin Gastroenterol; 2011 Apr; 45(4):309-13. PubMed ID: 21389810
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori therapy demystified.
Graham DY; Dore MP
Helicobacter; 2011 Oct; 16(5):343-5. PubMed ID: 21923679
[TBL] [Abstract][Full Text] [Related]
14. Current and Future Treatment of Helicobacter pylori Infections.
Matsumoto H; Shiotani A; Graham DY
Adv Exp Med Biol; 2019; 1149():211-225. PubMed ID: 31016626
[TBL] [Abstract][Full Text] [Related]
15. Development of
Suzuki S; Esaki M; Kusano C; Ikehara H; Gotoda T
World J Gastroenterol; 2019 Apr; 25(16):1907-1912. PubMed ID: 31086459
[No Abstract] [Full Text] [Related]
16. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
Zou J; Dong J; Yu X
Helicobacter; 2009 Oct; 14(5):97-107. PubMed ID: 19751434
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?
Lv ZF; Wang FC; Zheng HL; Wang B; Xie Y; Zhou XJ; Lv NH
World J Gastroenterol; 2015 Feb; 21(8):2522-33. PubMed ID: 25741163
[TBL] [Abstract][Full Text] [Related]
18. Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials.
Wenzhen Y; Yumin L; Quanlin G; Kehu Y; Lei J; Donghai W; Lijuan Y
Intern Med; 2010; 49(12):1103-9. PubMed ID: 20558925
[TBL] [Abstract][Full Text] [Related]
19. Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.
Nyssen OP; McNicholl AG; Megraud F; Savarino V; Oderda G; Fallone CA; Fischbach L; Bazzoli F; Gisbert JP
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009034. PubMed ID: 27351542
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori eradication regimens in an antibiotic high-resistance European area: A cost-effectiveness analysis.
Papaefthymiou A; Liatsos C; Georgopoulos SD; Apostolopoulos P; Doulberis M; Kyriakos N; Giakoumis M; Papadomichelakis M; Galanopoulos M; Katsinelos P; Rokkas T; Kountouras J
Helicobacter; 2020 Feb; 25(1):e12666. PubMed ID: 31692137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
